Forbes December 4, 2024
Alex Knapp

Plus: UnitedHealthcare CEO was fatally shot

This week, the FDA issued recommendations for streamlining the clearance process for AI-powered medical devices. The memo announcing this change recognizes that the utilization of AI in devices “is an iterative process” and aims to make it easier to improve software within the regulatory process.

The guidance, which is not legally enforceable but “describe the Agency’s current thinking” suggests that manufacturers could provide a plan for updating AI-powered software in medical devices that would reduce the need to file for a new clearance from the regulatory body. Instead, manufacturers would submit proposed changes to software, a proposal for testing those changes for safety and efficacy and strategies to minimize the risk of updates.

UnitedHealthcare...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Technology
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency
Opinion: To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully
5 Rare Diseases That Now Have Their First FDA-Approved Treatments
This Bill Could Make It Legal for AI to Prescribe Medicine
STAT+: Trump’s FDA navigates layoffs, exits, and a new hire

Share This Article